Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2013

Open Access 01-12-2013 | Study protocol

Study protocol of Prednisone in episodic Cluster Headache (PredCH): a randomized, double-blind, placebo-controlled parallel group trial to evaluate the efficacy and safety of oral prednisone as an add-on therapy in the prophylactic treatment of episodic cluster headache with verapamil

Authors: Dagny Holle, Jan Burmeister, André Scherag, Claudia Ose, Hans-Christoph Diener, Mark Obermann

Published in: BMC Neurology | Issue 1/2013

Login to get access

Abstract

Background

Episodic cluster headache (ECH) is a primary headache disorder that severely impairs patient’s quality of life. First-line therapy in the initiation of a prophylactic treatment is verapamil. Due to its delayed onset of efficacy and the necessary slow titration of dosage for tolerability reasons prednisone is frequently added by clinicians to the initial prophylactic treatment of a cluster episode. This treatment strategy is thought to effectively reduce the number and intensity of cluster attacks in the beginning of a cluster episode (before verapamil is effective). This study will assess the efficacy and safety of oral prednisone as an add-on therapy to verapamil and compare it to a monotherapy with verapamil in the initial prophylactic treatment of a cluster episode.

Methods and design

PredCH is a prospective, randomized, double-blind, placebo-controlled trial with parallel study arms. Eligible patients with episodic cluster headache will be randomized to a treatment intervention with prednisone or a placebo arm. The multi-center trial will be conducted in eight German headache clinics that specialize in the treatment of ECH.

Discussion

PredCH is designed to assess whether oral prednisone added to first-line agent verapamil helps reduce the number and intensity of cluster attacks in the beginning of a cluster episode as compared to monotherapy with verapamil.

Trial registration

German Clinical Trials Register DRKS00004716
Appendix
Available only for authorised users
Literature
1.
Headache Classification Subcommittee of the International Headache Society: The international classification of headache disorders: 2nd edition. Cephalalgia. 2004, 24: 9-160.CrossRef
2.
May A, Leone M, Afra J, Linde M, Sándor PS, Evers S, Goadsby PJ: EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol. 2006, 13 (10): 1066-1077. 10.1111/j.1468-1331.2006.01566.x.CrossRefPubMed
3.
May A, Evers S, Straube A, Pfaffenrath V, Diener HC: Treatment and prophylaxis for cluster headaches and other trigeminal autonomic headaches. Revised recommendations of the German Migraine and Headache Society. Schmerz. 2005, 19 (3): 225-241. 10.1007/s00482-005-0397-8.CrossRefPubMed
4.
Gaul C, Diener HC, Müller OM: Cluster headache: clinical features and therapeutic options. Dtsch Arztebl Int. 2011, 108 (33): 543-549.PubMedPubMedCentral
5.
Leone M, D’Amico D, Frediani F, Moschiano F, Grazzi L, Attanasio A, Bussone G: Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology. 2000, 54 (6): 1382-1385. 10.1212/WNL.54.6.1382.CrossRefPubMed
6.
Antonaci F, Costa A, Candeloro E, Sjaastad O, Nappi G: Single high-dose steroid treatment in episodic cluster headache. Cephalalgia. 2005, 25 (4): 290-295. 10.1111/j.1468-2982.2004.00855.x.CrossRefPubMed
7.
Couch JR, Ziegler DK: Prednisone therapy for cluster headache. Headache. 1978, 18 (4): 219-221. 10.1111/j.1526-4610.1978.hed1804219.x.CrossRefPubMed
8.
Jammes JL: The treatment of cluster headaches with prednisone. Dis Nerv Syst. 1975, 36 (7): 375-376.PubMed
9.
Kudrow L: Comparative results of prednisone, methysergid, and lithium therapy in cluster headache. Current Concepts in Migraine Research. Edited by: Green R. 1978, New York: Raven, 1-196.
10.
Mir P, Alberca R, Navarro A, Montes E, Martínez E, Franco E, Cayuela A, Lozano P: Prophylactic treatment of episodic cluster headache with intravenous bolus of methylprednisolone. Neurol Sci. 2003, 24 (5): 318-321. 10.1007/s10072-003-0182-3.CrossRefPubMed
11.
Reija G, Nider G, Koscica N, Negro C, Musco G: Dexamethasone in the treatment of episodic cluster headaches: an open study of 18 patients. Funct Neurol. 1998, 13: 171-172.
12.
Krabbe A, Steiner TJ: Prophylactic treatment of cluster headache. Cluster headache syndrome in general practice. Basic concepts. Edited by: Sjaastad O, Giuseppe N. 2000, London: Smith-Gordon, 91-96.
13.
Duvoisin RC: The cluster headache. JAMA. 1972, 222 (11): 1403-1404. 10.1001/jama.1972.03210110043010.CrossRefPubMed
14.
Friedman AP, Mikropoulos HE: Cluster headaches. Neurology. 1958, 8 (9): 653-663. 10.1212/WNL.8.9.653.CrossRefPubMed
15.
16.
Ekbom K: Lithium for cluster headache: review of the literature and preliminary results of long-term treatment. Headache. 1981, 21 (4): 132-139. 10.1111/j.1526-4610.1981.hed2104132.x.CrossRefPubMed
17.
Manzoni GC, Bono G, Lanfranchi M, Micieli G, Terzano MG, Nappi G: Lithium carbonate in cluster headache: assessment of its short- and long-term therapeutic efficacy. Cephalalgia. 1983, 3 (2): 109-114. 10.1046/j.1468-2982.1983.0302109.x.CrossRefPubMed
18.
Ekbom K: Prophylactic treatment of cluster headache with a new serotonin antagonist, BC 105. Acta Neurol Scand. 1969, 45 (5): 601-610.CrossRefPubMed
19.
Leone M, D’Amico D, Moschiano F, Fraschini F, Bussone G: Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups. Cephalalgia. 1996, 16 (7): 494-496. 10.1046/j.1468-2982.1996.1607494.x.CrossRefPubMed
20.
Gallagher RM, Mueller LL, Freitag FG: Divalproex sodium in the treatment of migraine and cluster headaches. J Am Osteopath Assoc. 2002, 102 (2): 92-94.PubMed
21.
Hering R, Kuritzky A: Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia. 1989, 9 (3): 195-198.CrossRefPubMed
22.
Förderreuther S, Mayer M, Straube A: Treatment of cluster headache with topiramate: effects and side-effects in five patients. Cephalalgia. 2002, 22 (3): 186-189. 10.1046/j.1468-2982.2002.00339.x.CrossRefPubMed
23.
Láinez MJA, Pascual J, Pascual AM, Santonja JM, Ponz A, Salvador A: Topiramate in the prophylactic treatment of cluster headache. Headache. 2003, 43 (7): 784-789. 10.1046/j.1526-4610.2003.03137.x.CrossRefPubMed
24.
Schuh-Hofer S, Israel H, Neeb L, Reuter U, Arnold G: The use of gabapentin in chronic cluster headache patients refractory to first-line therapy. Eur J Neurol. 2007, 14 (6): 694-696. 10.1111/j.1468-1331.2007.01738.x.CrossRefPubMed
25.
El Amrani M, Massiou H, Bousser MG: A negative trial of sodium valproate in cluster headache: methodological issues. Cephalalgia. 2002, 22 (3): 205-208. 10.1046/j.1468-2982.2002.00349.x.CrossRefPubMed
26.
Pringsheim T, Magnoux E, Dobson CF, Hamel E, Aubé M: Melatonin as adjunctive therapy in the prophylaxis of cluster headache: a pilot study. Headache. 2002, 42 (8): 787-792. 10.1046/j.1526-4610.2002.02181.x.CrossRefPubMed
27.
Monstad I, Krabbe A, Micieli G, Prusinski A, Cole J, Pilgrim A, Shevlin P: Preemptive oral treatment with sumatriptan during a cluster period. Headache. 1995, 35 (10): 607-613. 10.1111/j.1526-4610.1995.hed3510607.x.CrossRefPubMed
28.
Mulder LJ, Spierings EL: Naratriptan in the preventive treatment of cluster headache. Cephalalgia. 2002, 22 (10): 815-817. 10.1046/j.1468-2982.2002.00424.x.CrossRefPubMed
29.
Zebenholzer K, Wöber C, Vigl M, Wessely P: Eletriptan for the short-term prophylaxis of cluster headache. Headache. 2004, 44 (4): 361-364. 10.1111/j.1526-4610.2004.04079.x.CrossRefPubMed
30.
Peres MFP, Stiles MA, Siow HC, Rozen TD, Young WB, Silberstein SD: Greater occipital nerve blockade for cluster headache. Cephalalgia. 2002, 22 (7): 520-522. 10.1046/j.1468-2982.2002.00410.x.CrossRefPubMed
31.
Busch V, Jakob W, Juergens T, Schulte-Mattler W, Kaube H, May A: Occipital nerve blockade in chronic cluster headache patients and functional connectivity between trigeminal and occipital nerves. Cephalalgia. 2007, 27 (11): 1206-1214. 10.1111/j.1468-2982.2007.01424.x.CrossRefPubMed
32.
Ambrosini A, Vandenheede M, Rossi P, Aloj F, Sauli E, Pierelli F, Schoenen J: Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain. 2005, 118 (1–2): 92-96.CrossRefPubMed
33.
Leroux E, Valade D, Taifas I, Vicaut I, Chagnon M, Roos C, Ducros A: Suboccipital steroid injections for transitional treatment of patients with more than 2 cluster headache attacks per day: a randomized, double-blind, placebo-controlled trial. Lancet Neurol. 2011, 10: 881-897. 10.1016/S1474-4422(11)70154-5.CrossRef
34.
Ware JE, Kosinski M, Keller SD: A 12-item short form health survey. Med Care. 1996, 34: 220-223. 10.1097/00005650-199603000-00003.CrossRefPubMed
35.
Kosinski M, Bayliss MS, Bjorner JB, Ware JE, Garber WH, Batenhorst A, Cady R, Dahlöf CG, Dowson A, Tepper S: A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res. 2003, 12: 963-974. 10.1023/A:1026119331193.CrossRefPubMed
36.
Hautzinger M, Bailer M: Allgemeine Depressions Skala. Manual. 1993, Göttingen: Beltz Test GmbH
37.
Guy W, et al: Clinical Global Impressions (CGI) Scale. Psychiatric Measures. Edited by: Rush J. 2000, Washington DC: APA
Metadata
Title
Study protocol of Prednisone in episodic Cluster Headache (PredCH): a randomized, double-blind, placebo-controlled parallel group trial to evaluate the efficacy and safety of oral prednisone as an add-on therapy in the prophylactic treatment of episodic cluster headache with verapamil
Authors
Dagny Holle
Jan Burmeister
André Scherag
Claudia Ose
Hans-Christoph Diener
Mark Obermann
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2013
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-13-99

Other articles of this Issue 1/2013

BMC Neurology 1/2013 Go to the issue

Research article

Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study

Case report

Deterioration of pre-existing hemiparesis due to injury of the ipsilateral anterior corticospinal tract

Research article

An ultrasound model to calculate the brain blood outflow through collateral vessels: a pilot study

Research article

The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry

Case report

Paradoxical worsening of seizure activity with pregabalin in an adult with isodicentric 15 (IDIC-15) syndrome involving duplications of the GABRB3, GABRA5 and GABRG3 genes

Study protocol

V-TIME: a treadmill training program augmented by virtual reality to decrease fall risk in older adults: study design of a randomized controlled trial